Arkema S.A. (OTCMKTS:ARKAY - Get Free Report) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 3,700 shares, a decline of 24.5% from the September 15th total of 4,900 shares. Based on an average trading volume of 7,100 shares, the short-interest ratio is presently 0.5 days.
Arkema Trading Down 0.0 %
Shares of ARKAY stock traded down $0.02 during trading on Friday, hitting $94.78. 2,144 shares of the stock traded hands, compared to its average volume of 4,008. The firm has a market capitalization of $7.11 billion, a P/E ratio of 18.73, a price-to-earnings-growth ratio of 0.42 and a beta of 1.27. Arkema has a 52-week low of $84.55 and a 52-week high of $114.15. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.86 and a quick ratio of 1.38. The firm's fifty day moving average price is $90.57 and its 200-day moving average price is $95.64.
Arkema (OTCMKTS:ARKAY - Get Free Report) last issued its quarterly earnings data on Thursday, August 1st. The basic materials company reported $2.98 earnings per share (EPS) for the quarter. Arkema had a return on equity of 8.18% and a net margin of 3.80%. The firm had revenue of $2.73 billion during the quarter. As a group, research analysts forecast that Arkema will post 9.09 earnings per share for the current fiscal year.
Arkema Company Profile
(
Get Free Report)
Arkema SA manufactures and sells specialty chemicals and advanced materials worldwide. The company operates in three segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment provides solutions for construction, renovation of buildings, DIY, durable goods, and packaging and non-woven applications; and supplies technologies used in building activities for businesses and individuals, including sealants, tiles, flooring adhesives and waterproofing systems, and technologies used in industry, which include automotive, textiles, glazing, flexible and rigid packaging, and hygiene markets.
Featured Stories
Before you consider Arkema, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arkema wasn't on the list.
While Arkema currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.